CME Group Inc (CME) Receives Consensus Rating of “Hold” from Analysts

Shares of CME Group Inc (NASDAQ:CME) have been given a consensus recommendation of “Hold” by the seventeen research firms that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $192.79.

A number of brokerages recently commented on CME. BidaskClub lowered CME Group from a “sell” rating to a “strong sell” rating in a research report on Friday, March 22nd. Barclays dropped their target price on CME Group from $210.00 to $193.00 and set an “overweight” rating on the stock in a research report on Tuesday. Deutsche Bank dropped their target price on CME Group from $220.00 to $214.00 and set a “buy” rating on the stock in a research report on Friday, March 15th. ValuEngine lowered CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 20th. Finally, Zacks Investment Research lowered CME Group from a “buy” rating to a “hold” rating in a research report on Friday, December 7th.

In other CME Group news, CFO John W. Pietrowicz sold 17,960 shares of the business’s stock in a transaction that occurred on Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total value of $3,357,083.20. Following the completion of the transaction, the chief financial officer now directly owns 44,780 shares of the company’s stock, valued at $8,370,277.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Martin J. Gepsman sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $167.91, for a total value of $503,730.00. Following the completion of the transaction, the director now directly owns 39,799 shares of the company’s stock, valued at $6,682,650.09. The disclosure for this sale can be found here. Insiders sold 43,949 shares of company stock valued at $7,885,404 over the last three months. 0.43% of the stock is currently owned by corporate insiders.

A number of large investors have recently made changes to their positions in CME. Oregon Public Employees Retirement Fund lifted its holdings in CME Group by 18,502.9% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 16,220,459 shares of the financial services provider’s stock valued at $86,000 after acquiring an additional 16,133,266 shares during the period. Capital Research Global Investors lifted its holdings in CME Group by 107.8% in the third quarter. Capital Research Global Investors now owns 10,906,683 shares of the financial services provider’s stock valued at $1,856,427,000 after acquiring an additional 5,658,108 shares during the period. FMR LLC lifted its holdings in CME Group by 114.7% in the fourth quarter. FMR LLC now owns 6,198,088 shares of the financial services provider’s stock valued at $1,165,984,000 after acquiring an additional 3,310,989 shares during the period. Norges Bank acquired a new position in CME Group in the fourth quarter valued at approximately $597,417,000. Finally, Capital International Investors lifted its holdings in CME Group by 18.3% in the third quarter. Capital International Investors now owns 15,425,378 shares of the financial services provider’s stock valued at $2,625,554,000 after acquiring an additional 2,383,280 shares during the period. 84.84% of the stock is owned by institutional investors.

Shares of CME stock traded up $1.82 during trading hours on Friday, reaching $164.58. 1,018,775 shares of the company’s stock were exchanged, compared to its average volume of 1,875,538. CME Group has a 1 year low of $153.90 and a 1 year high of $197.08. The firm has a market capitalization of $58.24 billion, a price-to-earnings ratio of 24.13, a PEG ratio of 2.06 and a beta of 0.31. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.01 and a current ratio of 1.01.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.02. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.22 billion. During the same quarter in the previous year, the firm earned $1.12 earnings per share. The company’s revenue was up 37.4% on a year-over-year basis. As a group, equities analysts forecast that CME Group will post 7.04 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Monday, March 25th. Investors of record on Friday, March 8th were given a $0.75 dividend. The ex-dividend date was Thursday, March 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.82%. This is a positive change from CME Group’s previous quarterly dividend of $0.70. CME Group’s dividend payout ratio is currently 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: Penny Stocks, Risk and Reward Factors

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.